New Pill Reduces ‘Bad’ Cholesterol Levels by Almost 60%

Health & LifestyleNews
341

Listen to article (english)

Translate to Spanish or other 102 languages!

The study recruited people with heterozygous familial hypercholesterolemia, a genetic condition that causes the individual to have high levels of LDL, or “bad” cholesterol. Image for illustration purposes
The study recruited people with heterozygous familial hypercholesterolemia, a genetic condition that causes the individual to have high levels of LDL, or “bad” cholesterol. Image for illustration purposes

Mega Doctor News

- Advertisement -

Medical News Today

A recent study published in JAMA on November 9, investigates a drug called enlicitide. 

The study recruited people with heterozygous familial hypercholesterolemia, a genetic condition that causes the individual to have high levels of LDL, or “bad” cholesterol.

- Advertisement -

For these individuals, lifestyle changes and statins are often inadequate to bring their levels of LDL cholesterol down.

Follow the link below to Medical News Today to read the full story:

https://www.medicalnewstoday.com/articles/oral-pill-enlicitide-reduces-bad-cholesterol-levels-statins?utm_term=feature&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2025-11-26&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

Information source: https://www.medicalnewstoday.com

- Advertisement -

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Importance of Knowing Family Health History
Next article
DHR Health Earns an ‘A’ Hospital Safety Grade

More Articles

New UT Dell Campus Set to Expand Medical Education and Research in Central Texas

Governor Greg Abbott joined The University of Texas (UT) to announce the UT Dell Campus for Advanced Research. Photo: Office of The Governor

TMA Names Waco Physician Bradford Holland as New President

The Texas Medical Association (TMA) installed Waco otolaryngologist Bradford W. Holland, MD, as its 161st president during TexMed, TMA’s annual conference.

Houston Neurologist Chosen as TMA President-Elect

The Texas Medical Association (TMA) elected Kimberly E. Monday, MD, president-elect in April 2026 during TexMed, TMA’s annual conference. The Houston neurologist will serve one year in this office before becoming president.

Larger Families Associated With Reduced Stroke Risk, New UT Health San Antonio Research Shows

Research co-led by UT Health San Antonio, the academic health center of The University of Texas at San Antonio, associates a greater number of live births with a reduced risk of stroke or brain damage for mothers.
- Advertisement -